This post has been archived and contains information that may be out of date.
The Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration has extended its COVID-19 pandemic rules for prescribing controlled substances via telemedicine through Dec. 31, 2024. The regulation is effective Nov. 11.
This content is restricted to members.
